Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Clinical trial NCT03020030 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03020030
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-03
- Primary completion
- 2026-11-30
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.